Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer von Bratt, Ola, Folkvaljon, Yasin, Hjälm Eriksson, Marie, Akre, Olof, Carlsson, Stefan, Drevin, Linda, Franck Lissbrant, Ingela, Makarov, Danil, Loeb, Stacy, Stattin, Pär

Volltext

The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer von Crippa, Alessio, De Laere, Bram, Discacciati, Andrea, Larsson, Berit, Connor, Jason T., Gabriel, Erin E., Thellenberg, Camilla, Janes, Elin, Enblad, Gunilla, Ullen, Anders, Hjalm-Eriksson, Marie, Oldenburg, Jan, Ost, Piet, Lindberg, Johan, Eklund, Martin, Gronberg, Henrik

Volltext

Time difference in retrieving clinical information in Patient-overview Prostate Cancer compared to electronic health records von Alverbratt, Charlotte, Vikman, Hanna, Hjälm Eriksson, Marie, Stattin, Pär, Franck Lissbrant, Ingela

Volltext

Set-up and preliminary results from the Patient-overview Prostate Cancer. Longitudinal registration of treatment of advanced prostate cancer in the National Prostate Cancer Registe... von Franck Lissbrant, Ingela, Hjälm Eriksson, Marie, Lambe, Mats, Törnblom, Magnus, Stattin, Pär

Volltext

Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANA von Oudard, Stéphane, Fizazi, Karim, Sengeløv, Lisa, Daugaard, Gedske, Saad, Fred, Hansen, Steinbjørn, Hjälm-Eriksson, Marie, Jassem, Jacek, Thiery-Vuillemin, Antoine, Caffo, Orazio, Castellano, Daniel, Mainwaring, Paul N, Bernard, John, Shen, Liji, Chadjaa, Mustapha, Sartor, Oliver

Volltext

Long-term health-related quality of life after curative treatment for prostate cancer: A regional cross-sectional comparison of two standard treatment modalities von HJÄLM-ERIKSSON, MARIE, LENNERNÄS, BO, ULLÉN, ANDERS, JOHANSSON, HEMMING, HUGOSSON, JONAS, NILSSON, STEN, BRANDBERG, YVONNE

Volltext

High levels of health-related quality of life five years after curative treatment of prostate cancer with HDR-brachytherapy and external beam radiation von Hjälm-Eriksson, Marie, Ullén, Anders, Nilsson, Sten, Johansson, Hemming, Nilsson, Josef, Castellanos, Enrique, Brandberg, Yvonne

Volltext

Capture rate and representativity of The National Prostate Cancer Register of Sweden von Tomic, Katarina, Berglund, Anders, Robinson, David, Hjälm-Eriksson, Marie, Carlsson, Stefan, Lambe, Mats, Stattin, Pär

Volltext

Docetaxel Versus Surveillance After Radical Radiotherapy for Intermediate- or High-risk Prostate Cancer—Results from the Prospective, Randomised, Open-label Phase III SPCG-13 Trial... von Kellokumpu-Lehtinen, Pirkko-Liisa, Hjälm-Eriksson, Marie, Thellenberg-Karlsson, Camilla, Åström, Lennart, Franzen, Lars, Fransson, Ann-Sofie, Leskinen, Markku J., Zeke, Mihalj, Huttunen, Teppo, Ginman, Claes

Volltext

Time spent in hormone-sensitive and castration-resistant disease states in men with advanced prostate cancer, and its health economic impact: registry-based study in Sweden von Svensson, Johanna, Lissbrant, Ingela Franck, Gauffin, Oskar, Hjälm-Eriksson, Marie, Kilany, Suzanne, Fagerlund, Karin, Stattin, Pär

Volltext

High rate of local control and cure at 10 years after treatment of prostate cancer with external beam radiotherapy and high-dose-rate brachytherapy: a single centre experience von Hjälm-Eriksson, Marie, Nilsson, Sten, Brandberg, Yvonne, Johansson, Hemming, Lennernäs, Bo, Lundell, Göran, Castellanos, Enrique, Ullén, Anders

Volltext

Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden von Stattin, Pär, Westerberg, Marcus, Lissbrant, Ingela Franck, Eriksson, Marie Hjälm, Kjellman, Anders, Ullén, Anders, Vassilev, Zdravko, Sandstrom, Per, Weinrib, Rachel, Martinez, David, Garcia-Albeniz, Xabier

Volltext

Nationwide population-based study on the use of novel antiandrogens in men with prostate cancer in Sweden von Lissbrant, Ingela Franck, Ventimiglia, Eugenio, Robinson, David, Törnblom, Magnus, Hjalm-Eriksson, Marie, Lambe, Mats, Folkvaljon, Yasin, Stattin, Pär

Volltext

Comorbidity as a predictor of overall survival in prostate cancer patients treated with external beam radiotherapy combined with HDR brachytherapy boosts von Hjälm-Eriksson, Marie, Ullén, Anders, Johansson, Hemming, Levitt, Seymoure, Nilsson, Sten, Kälkner, Karl-Mikael

Volltext

The updated ESTRO core curricula 2011 for clinicians, medical physicists and RTTs in radiotherapy/radiation oncology von Eriksen, Jesper G, Beavis, Andrew W, Coffey, Mary A, Leer, Jan Willem H, Magrini, Stefano M, Benstead, Kim, Boelling, Tobias, Hjälm-Eriksson, Marie, Kantor, Guy, Maciejewski, Boguslaw, Mezeckis, Maris, Oliveira, Angelo, Thirion, Pierre, Vitek, Pavel, Olsen, Dag Rune, Eudaldo, Teresa, Enghardt, Wolfgang, François, Pascal, Garibaldi, Cristina, Heijmen, Ben, Josipovic, Mirjana, Major, Tibor, Nikoletopoulos, Stylianos, Rijnders, Alex, Waligorski, Michael, Wasilewska-Radwanska, Marta, Mullaney, Laura, Boejen, Annette, Vaandering, Aude, Vandevelde, Guy, Verfaillie, Christine, Pötter, Richard

Volltext

Docetaxel Versus Surveillance After Radical Radiotherapy for Intermediate- or High-risk Prostate Cancer-Results from the Prospective, Randomised, Open-label Phase III SPCG-13 Trial... von Kellokumpu-Lehtinen, Pirkko-Liisa, Hjalm-Eriksson, Marie, Thellenberg-Karlsson, Camilla, Astrom, Lennat, Franzen, Lars, Fransson, Ann-Fofie, Leskinen, Markku J., Zeke, Mihalj, Huttunen, Teppo, Ginman, Claes

Volltext

Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial (Aug, 10.1038/s41591-024-03204-2, 2024) von De, Laere B, Crippa, A, Discacciati, A, Larsson, B, Persson, M, Johansson, S, D'hondt, S, Bergstrom, R, Chellappa, V, Mayrhofer, M

Volltext

The ProBio trial : molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer von Crippa, Alessio, De Laere, Bram, Discacciati, Andrea, Larsson, Berit, Connor, Jason T, Gabriel, Erin E, Thellenberg, Camilla, Janes, Elin, Enblad, Gunilla, Ullen, Anders, Hjalm-Eriksson, Marie, Oldenburg, Jan, Ost, Piet, Lindberg, Johan, Eklund, Martin, Gronberg, Henrik

Volltext

Different fractionation schedules of radiotherapy to the primary tumor in metastatic hormone sensitive prostate cancer (Hypo-M1) von Thellenberg-Karlsson, Camilla, Kindblom, Jon, hjälm-Eriksson, Marie eva, Franck Lissbrant, Ingela, Beckman, Lars, Soderqvist, Karin, Styrke, Johan

Volltext

Corrigendum re “Docetaxel Versus Surveillance After Radical Radiotherapy for Intermediate- or High-risk Prostate Cancer—Results from the Prospective, Randomised, Open-label Phase I... von Kellokumpu-Lehtinen, Pirkko-Liisa, Hjälm-Eriksson, Marie, Thellenberg-Karlsson, Camilla, Åström, Lennat, Franzen, Lars, Fransson, Ann-Fofie, Leskinen, Markku J., Zeke, Mihalj, Huttunen, Teppo, Ginman, Claes

Volltext